Abiopharma

News list

📋 Ryan Charles E (Director) plans to sell 50K shares of Nebius Group N.V. (at $255.04 each, total $12.8M) Filed: Aug 14, 2026 | ID: 000293

Full text

News bot Aug. 14, 2026, 12:08 p.m.
📋 Form 144 Filing: Ryan Charles E

Company: Nebius Group N.V.

Filing Date: 2026-08-14

Relationship: Director; NON EXECUTIVE DIRECTOR
Planned Sale Details:
- Security: CLASS A ORDINARY SHARES
- Shares to be Sold: 50,000
- Price per Share: $255.04
- Total Value: $12,752,000.00
- Planned Sale Date: 2026-08-14
- Broker: CITIGROUP GLOBAL MARKETS
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-35173
- Issuer Contact Phone: 31202066970
- Issuer Address: SCHIPHOL BOULEVARD 165, SCHIPHOL, P7, 1118BG
- Broker Address: 390 GREENWICH ST, NEW YORK, NY, 10013
- Shares Outstanding: 271855218.0
- Number of Securities to be Sold: 1
- Remarks: UNDER SECTION 3 D MARKET PRICE IS BASED ON CLOSING PRICE AUGUST 13 OF 255.04 . SHARES ARE BEING SOLD PURSUANT TO A 10B51 PLAN DATED MAY 15 2026
- Signature: CONFORMED SIGNATURE ON FILE